Glucokinase activation - a strategy for T2D therapy: recent developments

Drug Discovery Today: Therapeutic Strategies

Volumn 4, Issue 2, 2007, Pages 111-115

  Sarabu, Ramakanth ^a   Taub, Rebecca ^b   Grimsby, Joseph ^b  

^a HOFFMANN LA ROCHE INC   (United States)

^b Hoffman La Roche Department of Metabolic Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYCLOHEXYL 1 (4 METHANESULFONYLPHENYL)CYCLOPROPANECARBOXYLIC ACID 2 THIAZOLYLAMIDE; ANTIDIABETIC AGENT; COMPOUND A; ENZYME ACTIVATOR; GKA 50; GLUCOKINASE; GLUCOKINASE ACTIVATOR; GLUCOSE; INSULIN; PSN GK 1; RO 281675 000; UNCLASSIFIED DRUG;

DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HIGH THROUGHPUT SCREENING; HUMAN; JUVENILE DIABETES MELLITUS; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW;

EID: 41949101206     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2007.10.009     Document Type: Review

References (21)

1. Sarabu R., and Grimsby J. Targeting glucokinase activation for the treatment of type 2 diabetes - a status review. Curr. Opin. Drug Discov. Dev. 8 (2005) 631-637
2. Kietzmann T., and Ganjam G.K. Glucokinase: old enzyme, new target. Expert Opin. Ther. Patents 15 (2005) 705-713
3. Van Schaftingen E. A protein from rat liver confers to glucokinase the property of antagonistically regulated by fructose-6-phosphate and fructose-1-phosphate. Eur. J. Biochem. 179 (1989) 179-183
4. Agius L., et al. Evidence for a role of glucose induced translocation of glucokinase in the control of hepatic glycogen synthesis. J. Biol. Chem. 271 (1996) 20379-20386
5. Gloyn A.L. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum. Mutat. 22 (2002) 252-262
6. Grimsby J., et al. Allosteric activators of glucokinase: potential role in diabetes therapy. Science 201 (2002) 270-272
7. Grimsby, J. et al. (2003) Discovery and actions of glucokinase activators. In Glucokinase and Glycemic Disease - From Basics to Therapeutics (Matschinsky, F.M. and Magnuson, M.A., eds), pp. 260-278
8. Brocklehurst K., et al. Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators. Diabetes 53 (2004) 535-541
9. McKerrecher D., et al. Design of a potent, soluble glucokinase activator with excellent in vivo efficacy. Bioorg. Med. Chem. Lett. 16 (2006) 2705-2709
10. Coope G.J., et al. Predictive blood glucose lowering efficacy by glucokinase activators in high fat fed female Zucker rats. Br. J. Pharmacol. (2006) 1-8
11. Johnson D., et al. Glucose-dependent modulation of insulin secretion and intracellular calcium ions by GKA50 - a glucokinase activator. Diabetes 56 (2007)
12. Futamura M., et al. An allosteric activator of glucokinase impairs the interaction of glucokinase regulatory protein and regulates glucose metabolism. J. Biol. Chem. 281 (2006) 37668-37674
13. Efanov A.M., et al. A novel glucokinase activator modulates pancreatic islet and hepatocyte function. Endocrinology 136 (2005) 2696-2701
14. Heuser S., et al. Synthesis of novel cyclopropylic sulfones and sulfonamides acting as glucokinase activators. Tetrahedron Lett. 47 (2006) 2675-2678
15. Fyfe M.C.T., et al. Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions. Diabetologia 50 (2007) 1277-1287
16. Neet K.E., et al. Observation of a kinetic slow transition in monomeric glucokinase. Biochemistry 29 (1990) 770-777
17. Cardenas M.L., et al. Suppression of kinetic cooperativity of hexokinase D (glucokinase) by competitive inhibitors. Eur. J. Biochem. 145 (1984) 163-171
18. Storer A.C., and Cornish-Bowden A. Kinetic evidence for a 'mnemonical' mechanism for rat liver glucokinase. Biochem. J. 165 (1977) 61-69
19. Kim Y.B., et al. A pre-steady state analysis of ligand binding to human glucokinase: evidence for a preexisting equilibrium. Biochemistry 46 (2007) 1423-1431
20. Kamata K., et al. Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. Structure 12 (2004) 429-438
21. Matschinsky F.M., et al. The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 55 (2006) 1-12